Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis

European Urology

Volumn 43, Issue 2, 2003, Pages 164-175

  Di Silverio, Franco ^a   Gentile, Vincenzo ^a   De Matteis, Anna ^a   Mariotti, Gianna ^a   Giuseppe, Voria ^a   Luigi, Pastore Antonio ^a   Sciarra, Alessandro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Benign prostatic hyperplasia; Histopathology; Prostate neoplasms; Prostate volume; Prostatic intraepithelial neoplasia

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOMA; ADULT; AGE; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RETROSPECTIVE STUDY; UROLOGIC SURGERY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ATROPHY; CARCINOMA; CHI-SQUARE DISTRIBUTION; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0037326098     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00548-1     Document Type: Article

References (43)

1. Foster CS. Pathology of benign prostatic hyperplasia. Prostate 2000;(Suppl 9):4-14.
2. Odunjo EO, Elebute EA. Chronic prostatitis in benign prostatic hyperplasia. Br J Urol 1971;43:333-7.
3. Nickel JC. Prostatic inflammation in benign prostatic hyperplasia - the third component? Can J Urol 1994;1:1-4.
4. Nickel JC, Downey J, Young I, Boag S. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. Br J Urol 1999;84:976-81.
5. Smith CJ, Gardner Jr WA. Inflammation-proliferation: possible relationships in the prostate. Prog Clin Biol Res 1987;239:317-25.
6. Bennett BD, Richardson PH, Gardner WA. Histopathology and cytology of prostatitis. In: Lepor H, Lawson RK, editors. Prostate diseases. Philadelphia: Saunders; 1993. p. 399-414.
7. McNeal JE. Normal histology of the prostate. Am J Surg Pathol 1988;12:619-33.
8. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999;155(6):1985-92.
9. Bostwick DG, Amin MB, Dundore P. Architectural pattems of high grade prostatic intraepithelial neoplasia. Hum Pathol 1993;24:298-310.
10. Helpap B, Bonkhoff H, Cockett A, Montironi R, Troncoso P, Waters D. Relationship between atypical adenomatous hyperplasia, prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Pathologica 1997;89:288-300.
11. Gaudin PB, Sesterhenn IA, Wojno KL, Mostofi FK, Epstein JI. Incidence and clinical significance of high grade prostatic intraepithelial neoplasia in TURP specimens. Urology 1997:49:558-63.
12. Bangma CH, Niemer AQ, Grobbe DE, Schroder FH. Transurethral ultrasonic volumetry of the prostate in vivo comparison of different methods. Prostate 1996;28:107-10.
13. Sobin LH, Wittekind CH, editors. TNM classification of malignant tumours. 5th ed. New York: Wiley; 1997. p. 180.2
14. Bostwick DG, Brawer MK. Prostatic intraepithelial neoplasia and early invasion in prostate cancer. Cancer 1987;59:788-94.
15. Drago JR, Mostofi FK, Lee F. Introductory remarks and workshop summary. Urology 1992;39:2-3.
16. Cheng L, Shan A, Cheville JC, Qian J, Bostwick DG. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res 1998;58:389-91.
17. Bostwick DG, Srigley J, Grignon D. Atypical adenomatous hyperplasia of the prostate: morphological criteria for its distinction from well differentiated carcinoma. Hum Pathol 1993;24:819-32.
18. Bostwick DG. Origins of prostate cancer. Cancer 1996;78:230-6.
19. Ruska KM, Sauvageot J, Epstein JI. Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol 1998;22(9):1073-7.
20. Anjum I, Ahmed M, Azzopardi A, Mufti GR. Prostatic infarction/ infection in acute urinary retention secondary to benign prostatic hyperplasia. J Urol 1998;160:792-3.
21. Mantel N. Chi-square tests with one degree of freedom: extensions of the Matel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
22. Armitage P. Statistical methods in medical research. New York: Wiley; 1971.
23. Cetinkaya M, Gunce S, Uluson E, Aksoy F, Yildiz O, Adsan O, Ozden C. Relationship between prostate specific antigen density, microvessel density and prostatic volume in benign prostatic hyperplasia and advanced prostatic carcinoma. Int Urol Nephrol 1998;30(5):581-5.
24. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol 1991;145:984-7.
25. Koyanagi T, Artibani W, Correa R. Diagnostic evaluation of men with lower urinary tract symptoms. In: Denis L, Griffiths K, Khoury S, editors. Fourth International Consultation on BPH, 1997 July; Paris. p. 181-257.
26. Aus G, Bergdahl S, Hugosson J, Norlen L. Volume determinations of the whole prostate and of adenomas by transrectal ultrasound in patients with clinically benign prostatic hyperplasia: correlation of resected weight, blood loss and duration of operation. Br J Urol 1994;73:659-63.
27. Mearini E, Marzi M, Zucchi A, Porena M. Open prostatectomy in benign prostatic hyperplasia: 10 year experience in Italy. Eur Urol 1998;34:480-5.
28. Gleason PE, Jones JA, Regan JS, Salvas DB, Eble JN. Platelet derived growth factor, androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia. J Urol 1993;149:1586-90.
29. Kessler OJ, Keisari Y, Servadio C, Abramovoci A. Role of chronic inflammation in the promotion of prostatic hyperplasia in rats. J Urol 1998;159:1049-53.
30. Bostwick DG, Montironi R, Sesterhenn IA. Diagnosis of prostatic intraepithelial neoplasia. Scand J Urol 2000;34(Suppl 205):3-10.
31. Helpap B. Differential diagnosis of glandular proliferations in the prostate. Virchow Arch 1998;433:397-405.
32. Moore RA. The morphology of small prostatic carcinoma. J Urol 1935;33:224-8.
33. Putzi MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 2000;56(5):828-32.
34. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986;17:64-71.
35. Sakr WA, Billis A, Ekman P, Wilt T, Bostwick DG. Epidemiology of high grade prostatic intraepithelial neoplasia. Scand J Urol 2000;34(Suppl 205):11-8.
36. Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissman JD. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol 1996;30:138-44.
37. Bostwick DG. High grade intraepithelial prostatic neoplasia. The most likely precursor of prostate cancer. Cancer 1995;75:1823-8.
38. Sakr WA, Haas GP, Cassis BR, Pontes JE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150:379-83.
39. Anderson GA, Lawson RK, Gottlieb MS. Quantitation of potentially undiagnosed incidental carcinoma of the prostate in patients treated nonsurgically for benign prostatic hyperplasia. Br J Urol 1993;72:465-9.
40. Tombal B, De Visccher L, Cosyns JP, Lorge F, Opsomer R, Wese FX, Van Cangh PJ. Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers. Br J Urol 1999;84:1015-20.
41. Di Silverio F, Sciarra A, D'Eramo G, et al. Relationship among age, PSA and prostate volume in men with LUTS and in different groups of men with and without benign and malignant prostate diseases. Prostate 1998;36:1-7.
42. Morote J, Lopez M, Encabo G, Torres IM. Effect of inflammation and benign prostatic enlargement on total and percent free serum PSA. Eur Urol 2000;37:537-40.
43. Brawer M. Prostatic intraepithelial neopalsia and PSA. Urology 1989;34(Suppl 6):62-5.